Telesis Bio Buy Hold or Sell Recommendation
| TBIODelisted Stock | USD 2.98 0.02 0.67% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Telesis Bio is 'Not Rated'. The recommendation algorithm takes into account all of Telesis Bio's available fundamental, technical, and predictive indicators you will find on this site.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. In addition, we conduct extensive research on individual companies such as Telesis and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Telesis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Telesis |
Execute Telesis Bio Buy or Sell Advice
The Telesis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Telesis Bio. Macroaxis does not own or have any residual interests in Telesis Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Telesis Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Telesis Bio Trading Alerts and Improvement Suggestions
| Telesis Bio is not yet fully synchronised with the market data | |
| Telesis Bio is way too risky over 90 days horizon | |
| Telesis Bio appears to be risky and price may revert if volatility continues | |
| Telesis Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 27.51 M. Net Loss for the year was (47.72 M) with profit before overhead, payroll, taxes, and interest of 15.6 M. | |
| Telesis Bio currently holds about 654.75 M in cash with (34.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company outstanding shares are owned by corporate insiders |
Telesis Bio Returns Distribution Density
The distribution of Telesis Bio's historical returns is an attempt to chart the uncertainty of Telesis Bio's future price movements. The chart of the probability distribution of Telesis Bio daily returns describes the distribution of returns around its average expected value. We use Telesis Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Telesis Bio returns is essential to provide solid investment advice for Telesis Bio.
| Mean Return | 1.33 | Value At Risk | -19.05 | Potential Upside | 18.58 | Standard Deviation | 20.41 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Telesis Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Nachtsheim Jami K of 70129 shares of Telesis Bio at 1.54 subject to Rule 16b-3 [view details]
Telesis Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Telesis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Telesis Bio Buy or Sell Advice
When is the right time to buy or sell Telesis Bio? Buying financial instruments such as Telesis Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Telesis Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 93 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |